Literature DB >> 8866578

Use of investigations in lower respiratory tract infection in the community: a European survey.

M Woodhead1, G Gialdroni Grassi, G J Huchon, P Léophonte, F Manresa, T Schaberg.   

Abstract

A questionnaire survey was performed on the use of investigations and their impact on treatment of adult lower respiratory tract infection in the community. Data on the management of 2,056 such infections were obtained simultaneously from general practitioners in France, Germany, Italy, Spain and the UK. Diagnostic tests were only performed in 29% of cases. Chest radiographs were performed most frequently (22%), followed by peripheral blood white cell count (15%) and microbiological examination of sputum (7%), with major differences being found in the frequency of these tests both by clinical diagnosis and country. A change in initial antibiotic therapy was made in 12% of cases, with use of investigation being significantly linked to such changes. Second- and third-line antibiotics were significantly different to first-line therapy, with macrolides the most frequently prescribed second-line and quinolones the most frequently prescribed third-line antibiotics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866578     DOI: 10.1183/09031936.96.09081596

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Providing better care for patients who may have pneumonia.

Authors:  W F Holmes; M Woodhead
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  A step forward in the everyday management of adults with community acquired pneumonia.

Authors:  Mark Woodhead; Theo J M Verheij
Journal:  BMJ       Date:  2005-01-31

3.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 4.  Azithromycin for acute lower respiratory tract infections.

Authors:  Malinee Laopaiboon; Ratana Panpanich; Kyaw Swa Mya
Journal:  Cochrane Database Syst Rev       Date:  2015-03-08

5.  Symptoms, signs, and prescribing for acute lower respiratory tract illness.

Authors:  W F Holmes; J T Macfarlane; R M Macfarlane; R Hubbard
Journal:  Br J Gen Pract       Date:  2001-03       Impact factor: 5.386

6.  Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics.

Authors:  Lulla Opatowski; Jonas Mandel; Emmanuelle Varon; Pierre-Yves Boëlle; Laura Temime; Didier Guillemot
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

7.  Reducing reconsultations for acute lower respiratory tract illness with an information leaflet: a randomized controlled study of patients in primary care.

Authors:  J T Macfarlane; W F Holmes; R M Macfarlane
Journal:  Br J Gen Pract       Date:  1997-11       Impact factor: 5.386

8.  Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life.

Authors:  Marc Miravitlles; Carles Llor; Jesús Molina; Karlos Naberan; Josep M Cots; Fernando Ros
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-02-18

9.  Serum protein electrophoresis: an interesting diagnosis tool to distinguish viral from bacterial community-acquired pneumonia.

Authors:  B Davido; C Badr; A Lagrange; S Makhloufi; P De Truchis; C Perronne; J Salomon; A Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-02       Impact factor: 3.267

Review 10.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.